Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DHODH and cancer: promising prospects to be explored
Yue Zhou, Lei Tao, Xia Zhou, et al.
Cancer & Metabolism (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives
Younis Ahmad Hajam, Raksha Rani, Shahid Yousuf Ganie, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 552-552
Open Access | Times Cited: 491
The diversified role of mitochondria in ferroptosis in cancer
Yue Liu, Shi-Ping Lu, Lei‐Lei Wu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 149
Ferroptosis in life: To be or not to be
Ling Xu, Yue Liu, Xi Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114241-114241
Open Access | Times Cited: 62
Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2023) Vol. 559, pp. 216119-216119
Closed Access | Times Cited: 52
Regulation of nucleotide metabolism in cancers and immune disorders
Eunüs S. Ali, Issam Ben‐Sahra
Trends in Cell Biology (2023) Vol. 33, Iss. 11, pp. 950-966
Open Access | Times Cited: 44
Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 27
A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression
Yongrui Hai, Renming Fan, Ting Zhao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107115-107115
Open Access | Times Cited: 10
A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
Yucheng Zheng, Shiliang Li, Kun Song, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 928-928
Open Access | Times Cited: 37
Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters
Min Gao, Kexin Fan, Yuhan Chen, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2022) Vol. 49, Iss. 10, pp. 913-926
Closed Access | Times Cited: 36
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
Lele Zhang, Jifa Zhang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114176-114176
Closed Access | Times Cited: 34
An In Silico Study of the Interactions of Alkaloids from Cryptolepis sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase
Lois Kwane Kyei, Edward Ntim Gasu, Gilbert Boadu Ampomah, et al.
Journal of Chemistry (2022) Vol. 2022, pp. 1-26
Open Access | Times Cited: 29
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy
Ying Tian, Yuan Xie, Zaixin Guo, et al.
Redox Biology (2023) Vol. 62, pp. 102708-102708
Open Access | Times Cited: 20
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Octavia Cadassou, Lars Petter Jordheim
Biochemical Pharmacology (2023) Vol. 211, pp. 115531-115531
Open Access | Times Cited: 19
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer
Shaoqiang Guo, Miaomiao Miao, Yufeng Wu, et al.
Oncogene (2024) Vol. 43, Iss. 19, pp. 1399-1410
Open Access | Times Cited: 7
Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response
Mengwei Zhang, Xu Sun, Yiwen Xu, et al.
Cell Biology International (2024) Vol. 48, Iss. 6, pp. 872-882
Closed Access | Times Cited: 6
Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
Yusong Luo, Guopeng Tian, Xiang Fang, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2123-2123
Open Access | Times Cited: 25
DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
Mengying Jiang, Yizuo Song, Hejing Liu, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 546-546
Open Access | Times Cited: 15
Menaquinone-4 attenuates ferroptosis by upregulating DHODH through activation of SIRT1 after subarachnoid hemorrhage
Jia-Tong Zhang, Qi Zhu, Zheng Peng, et al.
Free Radical Biology and Medicine (2023) Vol. 210, pp. 416-429
Closed Access | Times Cited: 15
Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis
Chieko Niwata, Takayuki Nakagawa, Takako Naruse, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Quinoline and quinolone carboxamides: A review of anticancer activity with detailed structure–activity relationship analysis
Neethu Mariam Thomas, Majed Alharbi, Venkanna Muripiti, et al.
Molecular Diversity (2025)
Closed Access
The Dynamic Role of Ferroptosis in Cancer Immunoediting: Implications for Immunotherapy
Jun Lan, Dan Cai, Shuang Gou, et al.
Pharmacological Research (2025) Vol. 214, pp. 107674-107674
Open Access
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation
Nicholas Dale D. Talubo, Estela Máris Amorim Cruz, Peter Matthew Paul Fowler, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 903-903
Open Access
Regulation of Mitochondrial Hydrogen Peroxide Availability by Protein S-glutathionylation
Ryan J. Mailloux, Cathryn Grayson, Olivia Koufos
Cells (2022) Vol. 12, Iss. 1, pp. 107-107
Open Access | Times Cited: 20
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top